3 days ago
TVTX
AnalystsYigal NochomovitzYigal Nochomovitz's Stock Forecasts
AnalystsYigal Nochomovitz
Sectors:
Analyst Ranking
Top 8%
#380 out of 5301 analysts
Average Return
+7.9%
Win Rate
48%153 out of 322
Risk vs Reward
Poor
Good
Yigal Nochomovitz's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Applied Therapeutics IncAPLT | +640.00% | $0.80 | $5.92 | 2023-04-04 - 2024-04-04 | Strong Buy |
Harpoon Therapeutics IncHARP | +381.72% | $4.76 | $22.93 | 2023-09-17 - 2024-02-26 | Strong Buy |
Reata Pharmaceuticals IncRETA | +334.02% | $38.27 | $166.10 | 2022-11-08 - 2023-08-01 | Strong Buy |
Harpoon Therapeutics IncHARP | +327.80% | $5.36 | $22.93 | 2023-10-23 - 2024-02-26 | Strong Buy |
Summit Therapeutics IncSMMT | +293.31% | $5.31 | $20.89 | 2024-05-06 - 2024-09-27 | Strong Buy |
Yigal Nochomovitz Analyst Color
Get additional color on Yigal Nochomovitz's coverage of popular stocks
9 days ago
STTK
15 days ago
TVTX
a month ago
RIGL
a month ago
NBIX
a month ago
ARVN
2 months ago
AVBP
2 months ago
LGND
2 months ago
TVTX
2 months ago
NBIX
3 months ago
BMEA
3 months ago
LGND
3 months ago
ARVN
3 months ago
CADL
3 months ago
OLMA
3 months ago
DRTS
3 months ago
ARVN
4 months ago
IDYA
4 months ago
KRYS
4 months ago
NBIX
5 months ago
KRYS
5 months ago
ARDX
5 months ago
KRYS
5 months ago
ARVN
5 months ago
KRYS
Yigal Nochomovitz's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Travere Therapeutics IncTVTX | 4 | Strong Buy | $70.00 | +29.29% | Maintains | 3 days ago |
Shattuck Labs IncSTTK | 8 | Strong Buy | $18.00 | +279.75% | Maintains | 9 days ago |
Mirum Pharmaceuticals IncMIRM | 1 | Strong Buy | $145.00 | +42.10% | Initiates Coverage On | 16 days ago |
Seaport Therapeutics IncSPTX | 1 | Strong Buy | $35.00 | +104.68% | Initiates Coverage On | 23 days ago |
Korro Bio IncKRRO | 1 | Strong Buy | $21.00 | +90.05% | Initiates Coverage On | a month ago |
Lenz Therapeutics IncLENZ | 6 | Strong Buy | $20.00 | +215.46% | Maintains | a month ago |
Arrivent Biopharma IncAVBP | 7 | Strong Buy | $43.00 | +37.12% | Maintains | a month ago |
Rigel Pharmaceuticals IncRIGL | 13 | Strong Buy | $81.00 | +142.73% | Maintains | a month ago |
Lexicon Pharmaceuticals IncLXRX | 8 | Strong Buy | $3.10 | +51.96% | Maintains | a month ago |
Acadia Pharmaceuticals IncACAD | 3 | Strong Buy | $32.00 | +48.15% | Maintains | a month ago |
Zai Lab LtdZLAB | 9 | Strong Buy | $44.00 | +146.09% | Maintains | a month ago |
Crispr Therapeutics AgCRSP | 20 | Strong Buy | $82.00 | +54.45% | Maintains | a month ago |
Neurocrine Biosciences IncNBIX | 5 | Strong Buy | $246.00 | +54.72% | Maintains | a month ago |
Oric Pharmaceuticals IncORIC | 8 | Strong Buy | $16.00 | +85.40% | Maintains | a month ago |
Krystal Biotech IncKRYS | 12 | Strong Buy | $378.00 | +10.64% | Maintains | a month ago |
Arvinas IncARVN | 13 | Strong Buy | $24.00 | +212.91% | Maintains | a month ago |
Ligand Pharmaceuticals IncLGND | 3 | Strong Buy | $282.00 | +7.17% | Maintains | 2 months ago |
Apellis Pharmaceuticals IncAPLS | 18 | Hold | $41.00 | -0.07% | Downgrades | 3 months ago |
Biomea Fusion IncBMEA | 12 | Strong Buy | $7.00 | +483.33% | Maintains | 3 months ago |
Sarepta Therapeutics IncSRPT | 3 | Strong Sell | $13.00 | -23.35% | Maintains | 3 months ago |
Candel Therapeutics IncCADL | 4 | Strong Buy | $26.00 | +225.41% | Maintains | 3 months ago |
Zenas Biopharma IncZBIO | 3 | Strong Buy | $41.00 | +120.67% | Maintains | 3 months ago |
Olema Pharmaceuticals IncOLMA | 4 | Strong Buy | $62.00 | +556.78% | Maintains | 3 months ago |
Alpha Tau Medical LtdDRTS | 2 | Strong Buy | $9.00 | -6.35% | Maintains | 3 months ago |
Eyepoint IncEYPT | 2 | Strong Buy | $35.00 | +166.16% | Maintains | 3 months ago |
Arcus Biosciences IncRCUS | 9 | Strong Buy | $45.00 | +86.57% | Maintains | 3 months ago |
Arcturus Therapeutics Holdings IncARCT | 10 | Hold | $8.00 | +8.70% | Maintains | 4 months ago |
Spyglass Pharma IncSGP | 1 | Strong Buy | $42.00 | +130.77% | Initiates Coverage On | 4 months ago |
Syndax Pharmaceuticals IncSNDX | 10 | Strong Buy | $57.00 | +199.37% | Maintains | 4 months ago |
Ideaya Biosciences IncIDYA | 4 | Strong Buy | $65.00 | +107.93% | Maintains | 4 months ago |
Ardelyx IncARDX | 13 | Strong Buy | $14.00 | +139.73% | Maintains | 5 months ago |
Beone Medicines LtdONC | 5 | Strong Buy | $405.00 | +54.18% | Maintains | 7 months ago |
Solid Biosciences IncSLDB | 2 | Strong Buy | $14.00 | +91.52% | Maintains | 7 months ago |
Caribou Biosciences IncCRBU | 6 | Strong Buy | $8.00 | +387.80% | Maintains | 7 months ago |
Summit Therapeutics IncSMMT | 6 | Strong Buy | $40.00 | +184.29% | Maintains | 8 months ago |
Merus NvMRUS | 15 | Hold | $97.00 | +7.78% | Downgrades | 9 months ago |
Zymeworks IncZYME | 13 | Strong Buy | $22.00 | -4.93% | Maintains | 10 months ago |
Prokidney CorpPROK | 2 | Strong Buy | $9.00 | +414.29% | Maintains | a year ago |
Applied Therapeutics IncAPLT | 8 | Strong Buy | $8.00 | N/A | Maintains | 2 years ago |
Macrogenics IncMGNX | 10 | Strong Buy | $14.00 | N/A | Maintains | 2 years ago |
Ovid Therapeutics IncOVID | 6 | Hold | $1.20 | N/A | Maintains | 2 years ago |
Calliditas Therapeutics AbCALT | 2 | Hold | $39.00 | N/A | Downgrades | 2 years ago |
Proqr Therapeutics NvPRQR | 3 | Hold | $2.00 | N/A | Maintains | 2 years ago |
Harpoon Therapeutics IncHARP | 9 | Hold | $23.00 | N/A | Downgrades | 2 years ago |
Mirati Therapeutics IncMRTX | 11 | Hold | $59.00 | N/A | Downgrades | 2 years ago |
Aldeyra Therapeutics IncALDX | 8 | Strong Buy | $8.00 | N/A | Maintains | 3 years ago |
Rain Oncology IncRAIN2 | 4 | Hold | $1.00 | N/A | Maintains | 3 years ago |
Eiger Biopharmaceuticals IncEIGRQ | 3 | Strong Buy | $90.00 | N/A | Maintains | 3 years ago |
Gracell Biotechnologies IncGRCL | 2 | Strong Buy | $11.00 | N/A | Maintains | 3 years ago |
Galera Therapeutics IncGRTX | 2 | Hold | $0.25 | N/A | Maintains | 3 years ago |
Atara Biotherapeutics IncATRA | 11 | Strong Sell | $35.00 | N/A | Maintains | 3 years ago |
Reata Pharmaceuticals IncRETA | 8 | Hold | $172.50 | N/A | Downgrades | 3 years ago |
Ultragenyx Pharmaceutical IncRARE | 10 | Strong Buy | $133.00 | N/A | Maintains | 3 years ago |
Unity Biotechnology IncUNBX | 6 | Strong Buy | $6.00 | N/A | Maintains | 3 years ago |
Cellectis SaCLLS | 2 | Strong Buy | $16.00 | N/A | Maintains | 3 years ago |
Fate Therapeutics IncFATE | 3 | Strong Buy | $10.00 | N/A | Maintains | 3 years ago |
Opthea LtdOPTEY | 2 | Strong Buy | $44.00 | N/A | Maintains | 4 years ago |
Innate Pharma SaIPHA | 1 | Strong Buy | $12.00 | N/A | Maintains | 4 years ago |
Aerie Pharmaceuticals IncAERI | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Dicerna Pharmaceuticals IncDRNA | 2 | Hold | $32.00 | N/A | Downgrades | 5 years ago |
Acceleron Pharma IncXLRN | 1 | Strong Buy | $171.00 | N/A | Maintains | 5 years ago |
Puma Biotechnology IncPBYI | 5 | Strong Buy | $70.00 | N/A | Maintains | 7 years ago |
Loxo Oncology IncLOXO | 6 | Strong Buy | $213.00 | N/A | Maintains | 8 years ago |
Keryx Biopharmaceuticals IncKERX | 2 | Hold | $4.00 | N/A | Maintains | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.